They also showed that the ALDH3A1 levels were significantly lower in patients with lymph node metastasis and poorer overall survival, with a similar p-value (0.037∗) to that in our study (p < 0.001). The gene discussed is ALDH3A1; the disease is metastatic malignant neoplasm in the lymph nodes.